Abstract | AIMS: A newly emerged Human Coronavirus (HCoV) is reported two months ago in Wuhan, China (COVID-19). Until today >2700 deaths from the 80,000 confirmed cases reported mainly in China and 40 other countries. Human to human transmission is confirmed for COVID-19 by China a month ago. Based on the World Health Organization (WHO) reports, SARS HCoV is responsible for >8000 cases with confirmed 774 deaths. Additionally, MERS HCoV is responsible for 858 deaths out of about 2500 reported cases. The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase (RdRp). MATERIALS AND METHODS: In this study, sequence analysis, modeling, and docking are used to build a model for Wuhan COVID-19 RdRp. Additionally, the newly emerged Wuhan HCoV RdRp model is targeted by anti-polymerase drugs, including the approved drugs Sofosbuvir and Ribavirin. KEY FINDINGS: The results suggest the effectiveness of Sofosbuvir, IDX-184, Ribavirin, and Remidisvir as potent drugs against the newly emerged HCoV disease. SIGNIFICANCE: The present study presents a perfect model for COVID-19 RdRp enabling its testing in silico against anti-polymerase drugs. Besides, the study presents some drugs that previously proved its efficiency against the newly emerged viral infection.
|
Authors | Abdo A Elfiky |
Journal | Life sciences
(Life Sci)
Vol. 248
Pg. 117477
(May 01 2020)
ISSN: 1879-0631 [Electronic] Netherlands |
PMID | 32119961
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Elsevier Inc. All rights reserved. |
Chemical References |
- Antiviral Agents
- IDX184
- Viral Proteins
- remdesivir
- Adenosine Monophosphate
- Ribavirin
- Guanosine Monophosphate
- Guanosine Triphosphate
- RNA-Dependent RNA Polymerase
- Alanine
- Uridine Triphosphate
- Sofosbuvir
|
Topics |
- Adenosine Monophosphate
(analogs & derivatives, chemistry, metabolism)
- Alanine
(analogs & derivatives, chemistry, metabolism)
- Alphacoronavirus
(enzymology, genetics)
- Amino Acid Sequence
- Antiviral Agents
(chemistry, metabolism)
- Betacoronavirus
(enzymology, genetics)
- COVID-19
- Catalytic Domain
- Computational Biology
(methods)
- Coronavirus Infections
(drug therapy, virology)
- Drug Repositioning
(methods)
- Guanosine Monophosphate
(analogs & derivatives, chemistry, metabolism)
- Guanosine Triphosphate
(chemistry, metabolism)
- Humans
- Molecular Docking Simulation
- Pneumonia, Viral
(drug therapy, virology)
- Protein Binding
- Protein Conformation, alpha-Helical
- Protein Conformation, beta-Strand
- Protein Interaction Domains and Motifs
- RNA-Dependent RNA Polymerase
(antagonists & inhibitors, chemistry, metabolism)
- Ribavirin
(chemistry, metabolism)
- SARS-CoV-2
- Sequence Alignment
- Sequence Homology, Amino Acid
- Sofosbuvir
(chemistry, metabolism)
- Thermodynamics
- Uridine Triphosphate
(chemistry, metabolism)
- Viral Proteins
(antagonists & inhibitors, chemistry, metabolism)
- COVID-19 Drug Treatment
|